Skip to main content

Put/Call Ratio

Updated Jun 24, 2026 at 2:35pm

Research Draft High 1,216 words

The put/call ratio (PCR) divides the number of put options traded by the number of call options traded over a period, yielding a single number that summarizes how much downside-protective or bearish options activity exists relative to upside or bullish activity. Because puts profit when prices fall and calls when they rise, a rising ratio is read as growing fear and a falling ratio as growing optimism. Its core tension is that it is almost always used contrarian — extreme fear is treated as a buy signal and extreme greed as a sell signal — which assumes the option-buying crowd is reliably wrong at extremes. That assumption is the contested part: the raw, publicly reported ratio mixes informed hedging with uninformed speculation, so its sentiment "signal" is noisy and its standalone predictive record is weak.

How it's calculated / formed

The formula is simply PCR = put volume ÷ call volume (a parallel version uses open interest instead of volume). The CBOE publishes three distinct daily series, and conflating them is the most common error:

  • Equity-only ($CPCE) — options on individual stocks. Structurally biased toward calls because retail speculators favor calls; StockCharts cites a roughly 0.61 long-run (200-day) average, i.e. well below 1.0.
  • Index ($CPCI) — options on indices (SPX, NDX, RUT, etc.). Structurally biased toward puts because institutions buy index puts as portfolio hedges regardless of view; StockCharts cites a ~1.41 long-run average.
  • Total ($CPC) — equity plus index combined; StockCharts cites a ~0.91 average.

Because the three baselines differ so much, thresholds are relative to each series, not absolute. For the raw equity-only series, StockCharts treats a spike above ~1.20 as excessive fear and a dip below ~0.70 as excessive greed (with the long-run 200-day average near 0.61); for the smoothed series it lowers the spike thresholds to roughly 0.95 (fear) and 0.80 (greed) because the moving average is less volatile. The daily series is noisy, so practitioners smooth it — a 10-day simple moving average is the most common — accepting added lag for cleaner extremes. There is no universal "correct" threshold; these are conventions that drift with regime and must be recalibrated.

How it's used in practice

The dominant use is contrarian extreme-spotting. A spike in the equity PCR signals capitulation — heavy put buying as the crowd panics — which contrarians treat as a potential bottom; an unusually low ratio signals complacency and a potential top. Because absolute thresholds drift, sophisticated users normalize: track the smoothed ratio's position within its own recent range (e.g. a Bollinger Band or percentile of the trailing year) rather than fixed cutoffs.

It is rarely used alone. The standard practice is confluence: a PCR extreme is treated as a condition, confirmed by price action (a reversal candle, a higher low) or another sentiment gauge before acting. PCR is also frequently paired with the VIX as a fear cross-check; the two often move together at panics, and agreement strengthens a capitulation read. A separate, more academically grounded use is single-name option ratios on individual stocks as a window into informed positioning, which is conceptually different from the index-level mood gauge.

Adoption, debate & evidence

PCR is one of the most widely watched sentiment indicators — quoted daily by the CBOE, StockCharts, and most financial media, and a staple of "fear and greed" dashboards. But the gap between its popularity and its measured edge is large, and honesty here matters.

The skeptical evidence is substantial. CXO Advisory's tests found the CBOE equity and total ratios have weak, inconsistent correlations with future SPY returns — the best variant explained under 1% of return variation (R² ≈ 0.006), and an extreme-threshold strategy (2004–2013) badly underperformed buy-and-hold even before costs. The academic literature is similarly mixed: results depend heavily on market, horizon (volume PCR helps over a few days, open-interest PCR over ~2 weeks in some studies), and methodology, and emerging-market findings don't transfer cleanly to the U.S.

Crucially, the strongest pro-PCR result is not about the raw public ratio. Pan and Poteshman (2006, Review of Financial Studies 19(3):871–908) found stocks with low put/call ratios outperformed those with high ratios by ~40 bps the next day and >1% over the next week — but they used proprietary, buyer-initiated, signed option volume that identifies who initiated each trade, attributing the edge to non-public information held by option traders, with stronger predictability in high-leverage contracts and stocks with more informed traders. The publicly reported CBOE PCR does not separate buyer- from seller-initiated flow or informed from uninformed traders, so it cannot capture most of that signal. Do not let the Pan–Poteshman result lend credibility to the raw ratio CNBC quotes — they are different instruments. "Folklore vs measured": the folklore that the PCR crowd is reliably wrong at extremes has real but modest support at genuine panic extremes; the everyday wiggles carry little reliable information.

Strengths & limitations

It works best as a coarse extreme detector at moments of genuine fear or euphoria, in confluence with price and other gauges, when applied to the correct series (equity-only for retail sentiment) with thresholds normalized to the current regime. It is a real-time, hard-data read on positioning, unlike survey sentiment.

It fails when: the wrong series is used (the index/total ratio is structurally elevated by hedging and produces false fear readings); fixed thresholds are applied across changing regimes; signals are taken in the trend's middle rather than at extremes; or growth in defined-risk and 0DTE option strategies and structural hedging keep distorting baselines over time. The #1 misuse is treating the Total or Index PCR as a sentiment gauge — its institutional-hedging put bias makes ratios above 1.0 normal, not bearish. A close second is mistaking ordinary daily fluctuation for a tradeable contrarian signal.

Sources

Disputes flagged: Standalone predictive value of the public PCR is contested (weak in U.S. simple tests vs. positive in some single-name/emerging-market and signed-volume studies). The robust academic result (Pan–Poteshman) uses proprietary signed volume, NOT the public ratio; these must not be conflated. Threshold values are conventions that drift with regime, not fixed constants.